Global Market Access

 

Global Market Access, Wednesday 24 April 2024

last published: 20/Apr/24 16:35

Global Market Access, Thursday 25 April 2024

Panel discussion
Global Market Access
12:00

Access to rare disease medicines in LMICs

Harpreet Ram, President, EVR Consulting
Aki Ko
Global Market Access
13:00

The promise of local cell therapy processing

Panel discussion
Charles Schmidt
Global Market Access
15:35

Equity in healthcare: Bridging the gap for diverse clinical representation

Panel discussion
Global Market Access
15:55

Why Investing in Rare? Innovative Solutions for Health Systems Financing

Rare diseases pose unique challenges to healthcare systems worldwide due to their low prevalence and complex treatment requirements. Traditional financing mechanisms often fail to adequately address the needs of patients with rare diseases, leading to disparities in access to treatment and care. However, innovative solutions are emerging to bridge this gap and ensure equitable access to healthcare for individuals affected by rare diseases. This session will explore the importance of investing in rare diseases and showcase innovative financing strategies that can support health systems in providing comprehensive care to patients with rare diseases.

Roberto Iunes, Senior Health Economist, World Bank
last published: 20/Apr/24 16:35

 

Get Involved At World Orphan Drug Congress USA

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Gina McHugh
gina.mchugh@terrapinn.com
t/ +1 646 619 1775

 

 

 

Marketing & Press Opportunities

 
 

Kaylie Brogan
kaylie.brogan@terrapinn.com